Lol Any sort of “monster” won’t be filed this year. Per last cc, everything is getting pushed out, which means about 18 months - 2 years away from hearing from approval standpoint.

Not a controlled substance, but has CNS properties. Used in UK for cocaine & meth addiction treatment. Studies in US showed it is ineffective for cocaine treatment. One big side effect is that vision continually worsens when on vigabatrin.

Yes, Elite uses “Elite Laboratories Inc” for FDA submissions. There is another Elite, but I believe it has more of a focus for pharmaceuticals & supplements within fitness industry. I think they use “Elite Labs” or something really close.

IR used to be around $400M market. Simply means it’s shrinking.

Execution means sales. Approval is great, but let’s see some decent partnership and sales. How many ANDAs have been approved that didn’t bring in any revenue under Nasrat’s management? I’m guessing that stat is about even at this point.

Adderall IR is closer to $0.5B market. Adderall ER is 2x IR market, but Lannett has bit the big one here making decent headway.

Looks like Amneal got approved as well for it last week. 13 competitors as FDA orange book doesn’t include Amneal yet + branded version with Lundbeck.

Lupin got approval for same earlier this year just few months ago.

According to IQVIA, Vigabatrin for Oral Solution USP had estimated annual sales of $275 million in the U.S in December 2021.

Not the CNS monster NASDAQ was waiting for. We might break into those when there are 10+ players in the market. Lol

Which one looks more ethical?

Excuse? That’s reality. Lol

Here’s the answer: huge bloat with over a billion shares outstanding in bloated with a lack of pipeline getting executed. Plus, with minimal communication to investors and CFO turnover (on 3rd within just a couple years). Doesn’t exude confidence.

Yes, but this is a cc from 2022. Opioid exclusion did not exist when we had the ANDAs initially approved many years ago.

Insurance was not an issue at the time, but did become an issue in the Pharma industry, but this was long after ANDAs were sold. Opioids never went away, especially generics. They were and still are heavily prescribed.

Elite would probably be more profitable with the opioid ANDAs they sold off for pennies on the dollar than they are today. Having a skittish lawyer for a CEO has proven detrimental. How many small manufacturers were sued or at risk of being sued? Z-E-R-O

Real securities are traded in dark pools. This should be no surprise.

How much has he been paid via deals via Mikah during his tenure vs how much shareholders have gained (actually lost) in share price during the same time period? Asking for a friend.

Not sure why any attempt is made between Elite and KBP. Contract mfg has little profit margin. If Nasrat goes this route, it’s a bad sign for company growth and organic opportunities.

Once again, this is why I said early Q4 when a poster said it was out of stock. Hoping it was resolved quickly. IR is the money maker and could have a signifiant impact.

Why was Elite’s Adderall IR out of stock earlier this quarter? Must have simply been a fluke.

Yes, that was Q3. Q4 is being reported next week.

Please do not post lies. This is not CNBC. I feel sorry for those that but into this.

Just an algorithmic response on market trends without substance. Definitely not a PR from the company. :)

Rebalance happens after today’s close if AMC is impacted.

Are you referring to the conference call announcement? Not much of a PR there.

Was wondering the same. Perhaps setting up for his dear friend Bill Gates.

More like a retail investor recording in their basement. lol

Would be nice, but we have yet to hit 9M. think we’ll see closer to 7-8M. I think we were out of API early Q4.

$5.4M would be sad to see and far below past 3 quarters. Would still be good amount over LY , but would not signify consistent sequential growth.

Why would a company issue a dividend if they are not consistently cash flow positive? That would be a pure waste of cash sending them closer to a restructuring or dilutive decision, driving through stock price lower. Not what is in the CEO’s playbook, especially when he is a shareholder.

Couple other volume transactions were just registered after it.

Don’t read into the timing. They are simply following SEC filing requirements for the K and holding cc right after.

Yes, but you can easily back into Q4 by subtracting YTD rev from Q3 10Q.

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022
Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022

NORTHVALE, NJ / ACCESSWIRE / June 23, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it would release its 2022 year-end financial results on Wednesday, June 29, 2022. Elite's management will host a live conference call Thursday, June 30th at 11:30 AM EDT to discuss the company's financial and operating results and provide a general business update. Stockholders should submit questions to the company before the call.

Date: June 30, 2022
Time: 11:30 AM EDT
Dial-in numbers: 1-800-346-7359 (domestic)
1-973-528-0008 (international)
Conference number: 98840
Questions: dianne@elitepharma.com
General questions by 5:00 PM EDT on Tuesday ...
Continue Reading

Cc just announced for 6/30

Thx for correction. So 3 weeks ago Berlin and Austin were burning up cash like crazy. Very little has changed since then. Cybertruck isn’t getting rolled out until next year for which Austin was created. Berlin is struggling all around hiring and retaining talent. Raising labor will simply eat into margins. Berlin just hit 1K/week in production. That plant is almost idle with how little it produces. Long way to go to increase productivity.

No, this is a statement that was from a recent interview posted online Wed.

Fremont has been running 24/7 for few years. Shanghai was running 24/7 pre-Covid. Berlin and Austin barely produce anything…

Not going to be enough to catch up to Q1.

There was some sarcasm. Be grateful there is still a value to Elite shares after 9 years of this.

Well, I should say you can attempt to sue for anything, but likelihood of winning is another story. Board represents shareholders, remember? They of course do what’s best for shareholder’s interests.

No